7,541.40

-38.67

-0.51%

51,983.98

+213.67

+0.41%

25,164.32

-272.68

-1.07%

2,805.88

-5.97

-0.21%

4.8940

-0.0350

-0.71%

21.15

+1.73

+8.91%

3,958.70

-10.90

-0.27%

76,688.62

-1,543.88

-1.97%

Crude Oil Dec 26

96.40

-0.06

-0.06%

US Private Equity

10,850.63

-82.20

-0.75%

NYSE American - Delayed Quote USD

Picard Medical, Inc. (PMI)

8.58 +0.23 (+2.75%)

At close: 4:00:00 PM EST

Loading Chart for PMI

Chart Range Bar

Interval:

In partnership with ChartIQ

Picard Medical Shares Soar After Quarterly Revenue Beats Forecasts

Picard Medical Shares Soar After Quarterly Revenue Beats Forecasts

Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026

Picard Medical / SynCardia Presents Emperor Total Artificial Heart Architecture for the First Time at IEEE EMBC 2026

Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance

Picard Medical Announces Reverse Stock Split Following Stockholder Approval to Support Continued NYSE American Listing Compliance

Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting

Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting

Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting

Picard Medical / SynCardia Releases Annual Stockholder Presentation Ahead of 2026 Annual Meeting

Picard Medical Announces Leadership Transition

Picard Medical Announces Leadership Transition

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Picard Medical and SynCardia to Present New In Vivo Emperor Total Artificial Heart Data and Patient Outcome Research at ASAIO 2026

Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies

Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies

PICARD MEDICAL, INC. Issues Letter to Shareholders

PICARD MEDICAL, INC. Issues Letter to Shareholders

Picard Medical / SynCardia Reports First Quarter 2026 Financial Results

Picard Medical / SynCardia Reports First Quarter 2026 Financial Results

Picard Medical Announces Pricing of $5 Million Offering

Picard Medical Announces Pricing of $5 Million Offering

Mobilize your Website

View Site in Mobile | Classic

Share by: